Clinical Trials

Less than a third of COVID-19 trials are led by women, half the proportion observed in non-COVID-19 trials

If approved for use, it would be the first drug to delay or prevent Type 1 diabetes

First peer-reviewed real-world study of COVID-19 vaccine examined 600,000 vaccinated individuals

This is the first randomized study to report on the role of combination checkpoint inhibitors for early stage NSCLC

A new type of drug that targets chemotherapy directly to cancer cells significantly increased patient survival

The first clinical efficacy results of the vaccine are based on a pre-specified pooled analysis of phase 3 trials in the UK and Brazil

The results are based on two dosing schedules, one of which is 90 percent effective

Robust antibody and T-cell response seen in older adults is encouraging

The vaccine trial reports 95 confirmed cases of COVID-19 with only 5 in the vaccinated group—a statistically significant result

Compared to inactive placebo, hydroxychloroquine did not significantly improve outcomes of hospitalized patients